LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 15 of 15: Calculated dose-response metrics. - Dataset (ID:20252)

Small Molecules Studied

HMS LINCS ID Name Alternative Names LINCS ID Structure Image PubChem CID
10127-1 Dovitinib
TKI_258; TKI258
 LSM-1127 49830557
10128-1 GSK 690693 LSM-1128 16048642
10132-1 SNS-032
BMS-387032
 LSM-1132 3025986
10133-1 Afatinib
BIBW-2992
 LSM-43226 57519523
10134-1 GSK1904529A LSM-1134 25124816
10135-1 Linsitinib
OSI 906
 LSM-1135 11640390
10138-1 Ruxolitinib LSM-1139 25126798
10140-1 Momelotinib
CYT387
 LSM-1141 25062766
10141-1 Fedratinib
SAR 302503; SAR-302503; SAR302503; TG 101348; Tg-101348; TG101348
 LSM-1142 16722836
10142-1 Trametinib
GSK-1120212; GSK1120212; GSK1120212B; JTP-74057
 LSM-1143 11707110
10146-1 Omipalisib
GSK2126458; GSK2126458A
 LSM-1147 25167777
10147-1 Buparlisib
BKM120; NVP-BKM120
 LSM-1148 16654980
10148-1 XL147
SAR245408
 LSM-1149 52914932
10149-1 Y39983 LSM-1150 9810884
10151-1 Nintedanib
BIBF-1120; Vargatef
 LSM-1152 56965894
10157-1 Foretinib
XL880; GSK1363089
 LSM-1158 42642645
10158-1 AZD 5438
KIN001-239
 LSM-1159 16747683
10159-1 Pelitinib
EKB-569
 LSM-1160 216467
10161-1 Luminespib
NVP-AUY922
 LSM-1162 53401173
10164-1 AZD8330
ARRY-424704; ARRY-704
 LSM-1165 16666708
10171-1 TGX221 LSM-1172 9907093
10172-1 GSK1059615 LSM-1173 71317162
10177-1 Brivanib
BMS-540215
 LSM-1178 11451527
10180-1 CHIR-99021
CT99021; KIN001-157
 LSM-1181 9956119
10182-1 Linifanib
ABT-869; AL-39324
 LSM-1183 11485656